The efficacy of sorafenib administration prior to TACE against the patients with intermediate HCC refractory to TACE
Not Applicable
Recruiting
- Conditions
- HCC
- Registration Number
- JPRN-UMIN000012636
- Lead Sponsor
- Keio University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with contraindication for sorafenib
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method TTP, ORR, OS